Skip to main content

Table 1 Prevalence of primary outcome by uterotonic drug in the published literature

From: Intramuscular oxytocin versus oxytocin/ergometrine versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth: study protocol for a randomised controlled trial (the IMox study)

 

Pooled prevalence:

need for subsequent additional uterotonic drugs

Percentage not requiring additional uterotonic drugs

Oxytocin

19.1%

80.9

Oxytocin/ergometrine

15.2%

84.8

Carbetocin

11.5%

88.5%

  1. Adapted from [12, 23]
Back to article page

Trials

ISSN: 1745-6215